A drug commonly prescribed for helping people quit smoking may increase the risk of developing cardiovascular event, according to new research.

While varenicline has been known to triple the chances of a person quitting smoking, patients who were prescribed the drug were 34 per cent more likely to have an emergency department visit or hospitalisation for a cardiovascular event while taking the drug.